Literature DB >> 21750217

Genomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines.

Venita Gresham Watson1, Nicholas E Hardison, Tyndall Harris, Alison Motsinger-Reif, Howard L McLeod.   

Abstract

We have attempted to use a familial genetics strategy to study mechanisms of topoisomerase 1 (Top1) inhibition. Investigations have steadily been chipping away at the pathways involved in cellular response following Top1 inhibition for more than 20 years. Our system-wide approach, which phenotypes a collection of genotyped human cell lines for sensitivity to compounds and interrogates all genes and molecular pathways simultaneously. Previously, we characterized the in vitro sensitivity of 15 families of Centre d'Etude Polymorphisme Humain (CEPH) cell lines (n = 142) to 9 camptothecin analogues. Linkage analysis revealed a pattern of 7 quantitative trait loci (QTL) shared by all of the camptothecins. To identify which, if any, QTLs are related to the general mechanism of Top1 inhibition or should be considered camptothecin specific, we characterized the in vitro sensitivity of the same panel of CEPH cell lines to the indenisoquinolones, a structurally distinct class of Top1 inhibitors. Four QTLs on chromosomes 1, 5, 11, and 16 were shared by both the camptothecins and the indenoisoquinolines and are considered associated with the general mechanism of Top1 inhibition. The remaining 3 QTLs (chromosomes 6 and 20) are considered specific to camptothecin-induced cytotoxicity. Finally, 8 QTLs were identified, which were unique to the indenoisoquinolines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750217      PMCID: PMC3191307          DOI: 10.1158/1535-7163.MCT-10-0872

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  21 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

2.  Gene expression analysis reveals chemical-specific profiles.

Authors:  Hisham K Hamadeh; Pierre R Bushel; Supriya Jayadev; Karla Martin; Olimpia DiSorbo; Stella Sieber; Lee Bennett; Raymond Tennant; Raymond Stoll; J Carl Barrett; Kerry Blanchard; Richard S Paules; Cynthia A Afshari
Journal:  Toxicol Sci       Date:  2002-06       Impact factor: 4.849

3.  Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.

Authors:  M Eileen Dolan; Karla G Newbold; Ramamoorthy Nagasubramanian; Xiaolin Wu; Mark J Ratain; Edwin H Cook; Judith A Badner
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

4.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.

Authors:  J Dausset; H Cann; D Cohen; M Lathrop; J M Lalouel; R White
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

5.  Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.

Authors:  A L Stark; W Zhang; S Mi; S Duan; P H O'Donnell; R S Huang; M E Dolan
Journal:  Pharmacogenomics J       Date:  2010-02-09       Impact factor: 3.550

6.  A first-generation physical map of the human genome.

Authors:  D Cohen; I Chumakov; J Weissenbach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

Review 7.  Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

Authors:  L L Jung; W C Zamboni
Journal:  Drug Resist Updat       Date:  2001-08       Impact factor: 18.500

8.  The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives.

Authors:  Yves Pommier; Mark Cushman
Journal:  Mol Cancer Ther       Date:  2009-04-21       Impact factor: 6.261

9.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity.

Authors:  James W Watters; Aldi Kraja; Melissa A Meucci; Michael A Province; Howard L McLeod
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

10.  Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.

Authors:  Smitha Antony; Muthusamy Jayaraman; Gary Laco; Glenda Kohlhagen; Kurt W Kohn; Mark Cushman; Yves Pommier
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  8 in total

1.  Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines.

Authors:  Chad C Brown; Tammy M Havener; Marisa W Medina; John R Jack; Ronald M Krauss; Howard L McLeod; Alison A Motsinger-Reif
Journal:  Pharmacogenomics       Date:  2014-02       Impact factor: 2.533

2.  Multivariate methods and software for association mapping in dose-response genome-wide association studies.

Authors:  Chad C Brown; Tammy M Havener; Marisa Wong Medina; Ronald M Krauss; Howard L McLeod; Alison A Motsinger-Reif
Journal:  BioData Min       Date:  2012-12-12       Impact factor: 2.522

3.  A comparison of association methods for cytotoxicity mapping in pharmacogenomics.

Authors:  Chad Brown; Tammy M Havener; Lorraine Everitt; Howard McLeod; Alison A Motsinger-Reif
Journal:  Front Genet       Date:  2011-12-14       Impact factor: 4.599

4.  Beyond IC50s: Towards Robust Statistical Methods for in vitro Association Studies.

Authors:  Andrew Beam; Alison Motsinger-Reif
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2014-03-01

5.  Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines.

Authors:  Kyle R Roell; Tammy M Havener; David M Reif; John Jack; Howard L McLeod; Tim Wiltshire; Alison A Motsinger-Reif
Journal:  Front Genet       Date:  2019-10-15       Impact factor: 4.599

Review 6.  The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era.

Authors:  Marylyn D Ritchie
Journal:  Hum Genet       Date:  2012-08-25       Impact factor: 4.132

7.  Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells.

Authors:  George W Small; Howard L McLeod; Kristy L Richards
Journal:  PeerJ       Date:  2013-02-12       Impact factor: 2.984

8.  A cellular genetics approach identifies gene-drug interactions and pinpoints drug toxicity pathway nodes.

Authors:  Oscar T Suzuki; Amber Frick; Bethany B Parks; O Joseph Trask; Natasha Butz; Brian Steffy; Emmanuel Chan; David K Scoville; Eric Healy; Cristina Benton; Patricia E McQuaid; Russell S Thomas; Tim Wiltshire
Journal:  Front Genet       Date:  2014-08-29       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.